Clinical Trials List
Protocol Number101-2623-E-075-004-NU
Not yet recruiting
2013-01-30 - 2013-12-31
Others
Terminated1
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- 王世楨 Division of Nuclear Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
0 participants
